Peer Reviewed
Factor XI inhibitors show promise as a safer alternative to direct oral anticoagulants for preventing and treating thrombosis, offering similar efficacy with reduced bleeding risk.
Jonathan Arnon, PharmD
Advertisement
Articles by Jonathan Arnon, PharmD
Advertisement
Latest Updated Articles
Factor XI Inhibitors: The Future of AnticoagulationMarch 18th 2025
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Panel Unanimously Backs Moderna’s Breakthrough mRNA Flu Vaccine Amid Political Turbulence
2
Sonrotoclax Plus Zanubrutinib Achieves Undetectable MRD Rates Above 90% in Frontline CLL/SLL
3
ADA 2026: Lipid Management and Cardiovascular Prevention Updates for People With Diabetes
4
McKesson ideaShare 2026: How AI and Automation Are Reshaping the Dispensing Experience
5